BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Fujisawa Healthcare, Inc. 

Parkway Center North
Three Parkway North
Deerfield  Illinois  60015-2548  U.S.A.
Phone: 800-888-7704 Fax: 847-317-7295


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Japanese Drugmakers Strengthen Area Ties 10/19/2005 5:13:10 PM    More...
Fujisawa Healthcare, Inc. And Roche (RHHBY) Announce Co-promotion Of MYCAMINE(TM) 10/19/2005 5:13:10 PM    More...
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval 10/19/2005 5:13:03 PM    More...
FDA Cautions Doctors On Eczema Treatment 10/19/2005 5:12:59 PM    More...
Cardiome Receives US$6 Million Milestone Payment 10/19/2005 5:12:49 PM    More...
US FDA Should Warn About Eczema Drug Risk-Panel 10/19/2005 5:12:45 PM    More...
Phase Forward Partners With Fujitsu To Promote InForm EDC Solution In Japan 10/19/2005 5:11:42 PM    More...
Fujisawa Healthcare Release: Ninety Six Percent Patient Survival Rate Shown In First-Ever Multi-Center, Double-Blind Study Of Early Steroid Withdrawal In Kidney Transplant Recipients 10/19/2005 5:11:26 PM    More...
Fujisawa Healthcare Release: Clinical Study Shows Safe And Well-Tolerated Conversion To Once Daily Tacrolimus From The Standard Prograf (Tacrolimus) Regimen In Stable Liver Transplant Recipients 10/19/2005 5:11:22 PM    More...
Fujisawa Healthcare Submits NDA For Treatment Of Esophageal Candidiasis 10/19/2005 5:11:04 PM    More...
12